...
首页> 外文期刊>Asian journal of surgery >Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors
【24h】

Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors

机译:远端胆管癌手术切除后的生存:系统评价和预后因素的荟萃分析

获取原文
           

摘要

Summary Background/Objective This study aimed to assess the available evidence on the survival of distal cholangiocarcinoma (DCC) patients following resection with curative intent and analyze the prognostic factors. Methods Relevant studies published between January 2000 and January 2015 were identified by searching PubMed and Embase and reviewed systematically. Summary relative risks (RR) and 95% confidence intervals (95% CI) were estimated using random-effects models. Results A total of 39 observational studies involving 3258 patients were included in the review. R0 resection was achieved in 84% (range, 46–100%) of patients. The median 5-year overall survival rate after resection was 37% (range, 13–54%), with corresponding rate of 44% (range, 27–63%) in R0 resection. The meta-analysis for 25 studies showed that R1 resection (RR 2.36, 95% CI 1.89–2.93), lymph node metastasis (RR 2.35, 95% CI 1.89–2.93), perineural invasion (RR 1.96, 95% CI 1.64–2.34), lymphatic invasion (RR 1.84, 95% CI 1.47–2.31), vascular invasion (RR 1.99, 95% CI 1.40–2.82), pancreatic invasion (RR 2.13, 95% CI 1.39–3.27), and pathological tumor stage ≥ T3 (RR 1.56, 95% CI 1.25–1.93) were associated with shorter survival. Conclusion In general, prognosis of DCC after resection is poor. R0 resection results in a substantially improved survival and represents one of the most important prognostic variables.
机译:摘要背景/目的本研究旨在评估可治愈的远端胆管癌(DCC)患者术后生存的可用证据,并分析其预后因素。方法通过检索PubMed和Embase来鉴定2000年1月至2015年1月之间发表的相关研究,并进行系统的综述。使用随机效应模型估算了总体相对风险(RR)和95%置信区间(95%CI)。结果本评价共纳入39项涉及3258例患者的观察性研究。 84%(46-100%)的患者实现了R0切除。切除后5年总生存率的中位数为37%(范围13–54%),R0切除术的相应比例为44%(范围27–63%)。对25项研究的荟萃分析显示,R1切除(RR 2.36,95%CI 1.89–2.93),淋巴结转移(RR 2.35,95%CI 1.89–2.93),神经周浸润(RR 1.96,95%CI 1.64–2.34)。 ),淋巴管浸润(RR 1.84,95%CI 1.47–2.31),血管浸润(RR 1.99,95%CI 1.40–2.82),胰腺浸润(RR 2.13,95%CI 1.39–3.27)和病理性肿瘤分期≥T3 (RR 1.56,95%CI 1.25–1.93)与较短的生存期相关。结论切除后DCC的预后一般较差。 R0切除术可显着提高生存率,是最重要的预后变量之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号